BCG Shortage 2019: Managing Through Treatment and Reimbursement Issues - Neal Shore, Ashish Kamat, and Jonathan Rubenstein

Neal Shore discusses the current 2019 shortage of BCG with Ashish Kamat and Jonathan Rubenstein. Bacillus Calmette-Guérin (BCG) is used as first-line intravesical therapy following tumor resection of non–muscle-invasive bladder cancer. Bacille Calmette-Guérin (BCG) has been a standard of care for many patients with non-muscle invasive bladder cancer for decades.Merck & Co., Inc., has advised that they anticipate a limited supply of BCG in the next year. Due to increasing global demand for BCG treatment and as the only source of TICE BCG in many countries, Merck anticipates this shortage to continue throughout 2019. UroToday will update the resources covering this situation as more information becomes available.


Jonathan N. Rubenstein M.D., Clinical Associate Professor, Department of Surgery, University of Maryland School of Medicine and is the Chief Compliance Officer, Chesapeake Urology Associates. Dr. Rubenstein is also the Chair of the American Urological Association Coding and Reimbursement Committee (CRC), a Member of the Regulatory Affairs Committee, American Urological Association, a Member, Telemedicine Committee, American Urological Association and a Member, Electronic Health Records (HER) Workgroup, American Urological Association. He is also a Member of the Laparoscopic Robotic and New Surgical Technology Committee, American Urological Association and an advisor representing the AUA on the American Medical Association, Alternate Current Procedural Terminology (CPT).

Neal Shore, MD The Medical Director of the Carolina Urologic Research Center. He practices with Atlantic Urology Clinics in Myrtle Beach, South Carolina.

Ashish Kamat, MD, MBBS Professor of Urology and Wayne B. Duddleston Professor of Cancer Research at MD Anderson Cancer Center in Houston, Texas.

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.